Supernus Pharmaceuticals, Inc

(NASDAQ:SUPN)

Latest On Supernus Pharmaceuticals, Inc (SUPN):

Date/Time Type Description Signal Details
2023-05-10 07:37 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 18:39 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78MN/A
2023-05-09 04:36 ESTNewsSupernus Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-04 20:51 ESTNewsSupernus Pharmaceuticals pays out $402M senior convertible notesN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals reports Q4 results, sees FY 2023 revenue in-lineN/A
2023-03-01 01:40 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q4 2022 Earnings Call TranscriptN/A
2023-02-27 20:04 ESTNewsSupernus Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-02-15 02:54 ESTNewsSupernus secures $150M line of credit from UBS Bank USAN/A
2023-02-10 18:44 ESTNewsSupernus: Earnings YearningsN/A
2022-11-30 06:36 ESTNewsSupernus Pharmaceuticals: Shares Could Get CheapN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.03 misses by $0.33, revenue of $177.35M beats by $4.87MN/A
2022-11-08 19:34 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 01:06 ESTNewsSupernus Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-10-10 17:31 ESTNewsSupernus stock falls 12.6% after FDA declines to approve Parkinson’s disease treatmentN/A
2022-09-10 04:18 ESTNewsSupernus Pharmaceuticals (SUPN) Investor Presentation - SlideshowN/A
2022-08-20 11:47 ESTNewsSupernus Pharmaceuticals: Deep Expertise In CNS, Eyes On Qelbree Launch And Parkinson PortfolioN/A
2022-08-07 11:02 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 17:16 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.14 misses by $0.15, revenue of $170.05M beats by $5.82MN/A
2022-08-04 02:17 ESTNewsSupernus Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-29 04:48 ESTNewsSupernus: A Work In ProgressN/A
2022-05-10 14:29 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 17:15 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.43 misses by $0.02, revenue of $152.51M beats by $2.04MN/A
2022-05-07 08:04 ESTNewsSupernus Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-05-02 09:21 ESTNewsSupernus rises on FDA label expansion of ADHD therapyN/A
2022-04-13 23:14 ESTNewsSupernus Pharmaceuticals GAAP EPS of $0.04 misses by $0.20, revenue of $159.05M in-lineN/A
2022-04-04 23:36 ESTNewsSupernus Pharmaceuticals drops 2.7% on 2022 guidanceN/A
2022-03-29 12:05 ESTNewsSupernus: New BeginningsN/A
2022-03-17 23:24 ESTNewsSupernus Pharmaceuticals notifies Nasdaq regarding non-compliance with listing ruleN/A
2022-03-01 13:25 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 00:52 ESTNewsSupernus Pharmaceuticals Q4 2021 Earnings PreviewN/A
2021-12-02 05:34 ESTNewsSupernus Pharma resumed Buy at Jefferies citing Adamas acquisitionN/A
2021-11-27 01:18 ESTNewsJasper more than doubles while M&A headlines weekly healthcare performersN/A
2021-11-04 16:57 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 19:31 ESTNewsSupernus Pharmaceuticals EPS beats by $0.17, beats on revenue; updates full year guidanceN/A
2021-11-03 19:30 ESTNewsSupernus up 10% following 2021 earnings guidance boost, Q3 beatN/A
2021-11-02 23:54 ESTNewsSupernus Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-27 03:49 ESTNewsAdamas Pharmaceuticals: An Acceptable Buyout At The Perfect TimeN/A
2021-10-11 18:00 ESTNewsSupernus to acquire Adamas in a deal worth up to $850 millionN/A
2021-10-11 17:59 ESTNewsAs Supernus acquires Adamas, other Parkinson's players mixed on the dayN/A
2021-09-03 02:57 ESTNewsFDA accepts for review Supernus' Qelbree sNDA for ADHD in adultsN/A
2021-08-26 01:08 ESTNewsSupernus: Well Prepared For Upcoming ChallengesN/A
2021-08-05 13:54 ESTNewsSupernus Pharmaceuticals EPS beats by $0.23, beats on revenueN/A
2021-08-05 13:53 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-03 19:03 ESTNewsSupernus Pharmaceuticals Q2 2021 Earnings PreviewN/A
2021-07-30 21:28 ESTNewsSupernus Pharma appoints Opgen executive as new CFON/A
2021-07-22 02:11 ESTNewsSupernus Pharma inks supply agreement with Bachem for key ingredient in ADHD drugN/A
2021-05-05 23:52 ESTNewsSupernus Pharmaceuticals EPS misses by $0.11, beats on revenue; reaffirms guidanceN/A
2021-05-05 23:51 ESTNewsSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2021 Results - Earnings Call TranscriptN/A
2021-05-05 03:39 ESTNewsSupernus Pharmaceuticals Q1 2021 Earnings PreviewN/A
2021-04-13 20:31 ESTNewsIRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst actionN/A

About Supernus Pharmaceuticals, Inc (SUPN):

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise APOKYN, a product indicated for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO, a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults. In addition, its product candidates include SPN-812, which has completed Phase III clinical trials that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a novel product candidate in Phase I clinical trials for treatment resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to conduct a Phase II clinical program for NV-5138 in treatment-resistant depression. The company was founded in 2005 and is headquartered in Rockville, Maryland.

See Advanced Chart

General

  • Name Supernus Pharmaceuticals, Inc
  • Symbol SUPN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 563
  • Fiscal Year EndDecember
  • IPO Date2012-05-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.supernus.com
View More

Valuation

  • Trailing PE 11.12
  • Forward PE 20.16
  • Price/Sales (Trailing 12 Mt.) 2.76
  • Price/Book (Most Recent Quarter) 1.9
  • Enterprise Value Revenue 2.66
  • Enterprise Value EBITDA 6.58
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.02
  • Next Year EPS Estimate $1.24
  • Next Quarter EPS Estimate $0.40
  • Profit Margin 24%
  • Operating Margin 36%
  • Return on Assets 9%
  • Return on Equity 19%
  • Revenue 520.4 million
  • Earnings Per Share $2.36
  • Revenue Per Share $9.89
  • Gross Profit 467.94 million
  • Quarterly Earnings Growth 42.9%
View More

Highlights

  • Market Capitalization 1.39 billion
  • EBITDA 206.24 million
  • PE Ratio 369.82
  • PEG Ratio 1.47
  • Analyst Target Price $30.75
  • Book Value Per Share $14.09
View More

Share Statistics

  • Shares Outstanding 52.92 million
  • Shares Float 47.91 million
  • % Held by Insiders 361%
  • % Held by Institutions 101.46%
  • Shares Short 7.47 million
  • Shares Short Prior Month 7.15 million
  • Short Ratio 14.42
  • Short % of Float 21%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta 1.29
  • 52 Week High $31.99
  • 52 Week Low $15.58
  • 50 Day Moving Average 28.34
  • 200 Day Moving Average 24.03
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Supernus Pharmaceuticals, Inc (SUPN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Supernus Pharmaceuticals, Inc (SUPN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.57$0.4916.33%
2020-09-302020-11-03$155.14 million$0.74$0.27170.76%
2020-06-302020-08-17$126.73 million$0.65$0.4254.76%
2020-03-312020-05-05$N/A$0.40$0.2653.85%
2019-12-312020-02-25$100.45 million$0.62$0.595.8%
2019-09-302019-11-05$102.14 million$0.54$0.59-8.47%
2019-06-302019-08-06$104.7 million$0.61$0.601.24%
2019-03-312019-05-07$85.47 million$0.34$0.47-26.88%
2018-12-312019-02-26$115.93 million$0.48$0.2967.19%
2018-09-302018-11-06$103 million$0.52$0.4222.93%
2018-06-302018-08-07$99.54 million$0.57$0.4526.67%
2018-03-312018-05-08$90.43 million$0.49$0.3251.94%
2017-12-312018-02-27$88.44 million$0.26$0.28-7.6%
2017-09-302017-11-06$80.4 million$0.30$0.286.71%
2017-06-302017-08-02$75.83 million$0.33$0.2436.5%
2017-03-312017-05-09$57.58 million$0.19$0.25-24%
2016-12-312017-01-20$62.37 million$0.37$0.347.19%
2016-09-302016-09-30$56.81 million$1.18$0.34247.06%
2016-06-302016-08-02$51.63 million$0.18$0.1336.67%
2016-03-312016-05-04$44.19 million$0.10$0.0913.8%
2015-12-312016-03-02$43.69 million$0.14$0.06128.83%
2015-09-302015-11-03$39.36 million$0.08$0.02300%
2015-06-302015-08-04$35.68 million$0.03$0.0250%
2015-03-312015-05-05$28.74 million$0.02-$0.01300%
2014-12-312015-03-10$31.24 million$0.10-$0.12183.33%
2014-09-302014-11-11$52.49 million$0.39$0.368.33%
2014-06-302014-08-11$29.68 million$0.08-$0.15153.33%
2014-03-312014-05-12$9.08 million-$0.35-$0.4114.63%
2013-12-312014-03-12$10.34 million-$0.39-$0.5529.09%
2013-09-302013-11-12$1.26 million-$0.64-$0.674.48%
2013-06-302013-08-13$281000-$0.57-$0.6512.31%
2013-03-312013-05-13$147000-$0.60-$0.7115.49%
2012-12-312013-03-14$1.09 million-$0.51-$0.7128.17%
2012-09-302012-11-07$92000-$0.55-$0.6211.29%
2012-06-302012-08-10$91000-$0.61-$0.48-27.08%
2012-03-312012-06-07$208000-$0.42

Supernus Pharmaceuticals, Inc (SUPN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Supernus Pharmaceuticals, Inc (SUPN) Chart:

Supernus Pharmaceuticals, Inc (SUPN) News:

Below you will find a list of latest news for Supernus Pharmaceuticals, Inc (SUPN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Supernus Pharmaceuticals, Inc (SUPN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-17200CALL0 0260.35TRUE00
2025-04-17250CALL0 075.38TRUE00
2025-04-17260CALL0 054.07TRUE00
2025-04-17270CALL0 046.05TRUE00
2025-04-17280CALL0 051.85TRUE00
2025-04-17290CALL0 048.48TRUE00
2025-04-17300CALL0 050.73TRUE00
2025-04-17310CALL0 034.12TRUE00
2025-04-17320CALL0 039.28TRUE00
2025-04-17330.5CALL0 222.26FALSE00
2025-04-17340.75CALL0 244.05FALSE00
2025-04-17350CALL0 031.77FALSE00
2025-04-17361.5CALL0 232.99FALSE00
2025-04-17370CALL0 052.88FALSE00
2025-04-17380CALL0 061.06FALSE00
2025-04-17390CALL0 067.56FALSE00
2025-04-17400CALL0 073.71FALSE00
2025-04-17410CALL0 0113.39FALSE00
2025-04-17420CALL0 0119.93FALSE00
2025-04-17430CALL0 0126.18FALSE00
2025-04-17440CALL0 0132.16FALSE00
2025-04-17450CALL0 0137.9FALSE00
2025-04-17460CALL0 0105.3FALSE00
2025-04-17470CALL0 0109.89FALSE00
2025-04-17480CALL0 0114.33FALSE00
2025-04-17200PUT0 0192.73FALSE00
2025-04-17250PUT0 0134.75FALSE00
2025-04-17260PUT0 082.69FALSE00
2025-04-17270PUT0 063.96FALSE00
2025-04-17280PUT0 075.32FALSE00
2025-04-17290.61PUT0 238.62FALSE00
2025-04-17300PUT0 066.29FALSE00
2025-04-17310PUT0 047.86FALSE00
2025-04-17320PUT0 030.03FALSE00
2025-04-17330PUT0 029.49TRUE00
2025-04-17342.7PUT0 215.6TRUE00
2025-04-17352.05PUT0 143.46TRUE00
2025-04-17360PUT0 071.7TRUE00
2025-04-17370PUT0 0109.27TRUE00
2025-04-17380PUT0 045.24TRUE00
2025-04-17390PUT0 050.79TRUE00
2025-04-17400PUT0 060.91TRUE00
2025-04-17410PUT0 053.82TRUE00
2025-04-17420PUT0 0159.92TRUE00
2025-04-17430PUT0 0163.15TRUE00
2025-04-17440PUT0 0165.97TRUE00
2025-04-17450PUT0 0179.81TRUE00
2025-04-17460PUT0 0189.67TRUE00
2025-04-17470PUT0 0195.58TRUE00
2025-04-17480PUT0 082.33TRUE00
2025-05-16200CALL0 053.42TRUE00
2025-05-16240CALL0 065.95TRUE00
2025-05-16250CALL0 053.4TRUE00
2025-05-16260CALL0 071.4TRUE00
2025-05-16270CALL0 051.28TRUE00
2025-05-16280CALL0 038.6TRUE00
2025-05-16290CALL0 040.99TRUE00
2025-05-16300CALL0 019.03TRUE00
2025-05-16310CALL0 052.34TRUE00
2025-05-16320CALL0 036.46TRUE00
2025-05-16330CALL0 030.31FALSE00
2025-05-16340CALL0 029.37FALSE00
2025-05-16350.71CALL0 032.85FALSE00
2025-05-16361CALL0 234.58FALSE00
2025-05-16370CALL0 034.49FALSE00
2025-05-16380CALL0 034.42FALSE00
2025-05-16390CALL0 032.28FALSE00
2025-05-16400CALL0 034.03FALSE00
2025-05-16450CALL0 064.67FALSE00
2025-05-16200PUT0 098.01FALSE00
2025-05-16240PUT0 067.87FALSE00
2025-05-16250PUT0 060.93FALSE00
2025-05-16260PUT0 074.63FALSE00
2025-05-16270PUT0 055.92FALSE00
2025-05-16280PUT0 062.12FALSE00
2025-05-16290PUT0 049.2FALSE00
2025-05-16300PUT0 041.22FALSE00
2025-05-16310PUT0 047.77FALSE00
2025-05-16320PUT0 026.26FALSE00
2025-05-16330PUT0 029.74TRUE00
2025-05-16340PUT0 038.54TRUE00
2025-05-16350PUT0 050.7TRUE00
2025-05-16360PUT0 041.46TRUE00
2025-05-16370PUT0 028.26TRUE00
2025-05-16380PUT0 047.2TRUE00
2025-05-16390PUT0 064.46TRUE00
2025-05-16400PUT0 042.74TRUE00
2025-05-16450PUT0 0118.87TRUE00
2025-06-202012.7CALL0 1054.49TRUE00
2025-06-20258CALL0 10165.71TRUE00
2025-06-20260CALL0 045.2TRUE00
2025-06-20270CALL0 034.83TRUE00
2025-06-20280CALL0 039.22TRUE00
2025-06-20290CALL0 042.96TRUE00
2025-06-203010CALL0 332.54TRUE00
2025-06-20313.27CALL0 828.81TRUE00
2025-06-20320CALL0 040.77TRUE00
2025-06-20332CALL0 128.68FALSE00
2025-06-20340CALL0 028.75FALSE00
2025-06-20352.04CALL0 326.12FALSE00
2025-06-20361.34CALL0 1736.68FALSE00
2025-06-20370.74CALL0 5328.8FALSE00
2025-06-20380.8CALL0 435.27FALSE00
2025-06-20391.3CALL0 1134.61FALSE00
2025-06-20400.2CALL0 8330.08FALSE00
2025-06-20413.3CALL0 2635.48FALSE00
2025-06-20450.85CALL0 1449.14FALSE00
2025-06-20501.55CALL0 660.25FALSE00
2025-06-20550.75CALL0 291.38FALSE00
2025-06-20600.55CALL0 1100.92FALSE00
2025-06-20200.55PUT0 4100.44FALSE00
2025-06-20250.85PUT0 771.95FALSE00
2025-06-20260.6PUT0 751.21FALSE00
2025-06-20271.25PUT0 452.85FALSE00
2025-06-20281.45PUT0 539.14FALSE00
2025-06-20291PUT0 248.97FALSE00
2025-06-20301.75PUT0 1235.19FALSE00
2025-06-20312.05PUT0 234.4FALSE00
2025-06-20321.9PUT0 1435.76FALSE00
2025-06-20332.55PUT0 3729.42TRUE00
2025-06-20343.2PUT0 140.48TRUE00
2025-06-20354PUT0 727.56TRUE00
2025-06-20360PUT0 020.94TRUE00
2025-06-20374.7PUT0 123.66TRUE00
2025-06-20385PUT0 137.99TRUE00
2025-06-20390PUT0 040.51TRUE00
2025-06-20400PUT0 056.96TRUE00
2025-06-20410PUT0 039.99TRUE00
2025-06-20450PUT0 087.62TRUE00
2025-06-20500PUT0 0106.05TRUE00
2025-06-20550PUT0 073.03TRUE00
2025-06-20600PUT0 0133.64TRUE00
2025-09-19200CALL0 041.48TRUE00
2025-09-19250CALL0 034.87TRUE00
2025-09-19305.8CALL0 6037.56TRUE00
2025-09-193110.1CALL0 133.18TRUE00
2025-09-19320CALL0 037.84TRUE00
2025-09-19333.1CALL0 129.59FALSE00
2025-09-19342CALL0 333.24FALSE00
2025-09-19352.5CALL0 636.33FALSE00
2025-09-19362CALL0 234.47FALSE00
2025-09-19371.75CALL0 134.09FALSE00
2025-09-19381.76CALL0 4025.28FALSE00
2025-09-19391.3CALL0 433.09FALSE00
2025-09-19400.9CALL0 1439.98FALSE00
2025-09-19412CALL0 135.6FALSE00
2025-09-19420.65CALL0 1133.09FALSE00
2025-09-19431.35CALL0 133.78FALSE00
2025-09-19440CALL0 042.47FALSE00
2025-09-19451.3CALL0 135FALSE00
2025-09-19460CALL0 033.12FALSE00
2025-09-19500.25CALL0 541.1FALSE00
2025-09-19551.55CALL0 247.76FALSE00
2025-09-19601.05CALL0 353.6FALSE00
2025-09-19200.19PUT0 253.43FALSE00
2025-09-19250.8PUT0 241.18FALSE00
2025-09-19301.65PUT0 227FALSE00
2025-09-19311.5PUT0 133.71FALSE00
2025-09-19322.67PUT0 631.82FALSE00
2025-09-19334.14PUT0 236.99TRUE00
2025-09-19343.6PUT0 132.52TRUE00
2025-09-19354.2PUT0 427.59TRUE00
2025-09-19364.8PUT0 234.3TRUE00
2025-09-19370PUT0 029.64TRUE00
2025-09-19380PUT0 033.38TRUE00
2025-09-19390PUT0 033.42TRUE00
2025-09-19400PUT0 036.07TRUE00
2025-09-19418.1PUT0 230.04TRUE00
2025-09-19420PUT0 037.56TRUE00
2025-09-19430PUT0 034.26TRUE00
2025-09-19440PUT0 061.87TRUE00
2025-09-19450PUT0 069.28TRUE00
2025-09-19460PUT0 058.3TRUE00
2025-09-19500PUT0 078.81TRUE00
2025-09-19550PUT0 049.8TRUE00
2025-09-19600PUT0 097.56TRUE00

Latest SUPN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$26.54
Jun 13, 2022 7:59 PM EST78$26.52
Jun 13, 2022 7:59 PM EST12$26.53
Jun 13, 2022 7:59 PM EST100$26.52
Jun 13, 2022 7:59 PM EST113$26.54

Supernus Pharmaceuticals, Inc (SUPN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2018-09-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018029835/0000000000-18-029835-index.htm
2018-11-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018034262/0000000000-18-034262-index.htm
2018-12-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000018037479/0000000000-18-037479-index.htm
2019-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019011207/0000000000-19-011207-index.htm
2019-08-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1356576/000000000019012145/0000000000-19-012145-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000021545719007287/0000215457-19-007287-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000083423720008681/0000834237-20-008681-index.htm
2020-03-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000091957420002390/0000919574-20-002390-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000093247119001355/0000932471-19-001355-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000104746919000828/0001047469-19-000828-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000104746919002684/0001047469-19-002684-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918032082/0001104659-18-032082-index.htm
2018-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032502/0001104659-18-032502-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918034093/0001104659-18-034093-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918037201/0001104659-18-037201-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918039860/0001104659-18-039860-index.htm
2018-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043589/0001104659-18-043589-index.htm
2018-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043595/0001104659-18-043595-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043597/0001104659-18-043597-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918047769/0001104659-18-047769-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918050207/0001104659-18-050207-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918050920/0001104659-18-050920-index.htm
2018-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055089/0001104659-18-055089-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918055660/0001104659-18-055660-index.htm
2018-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057416/0001104659-18-057416-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918057845/0001104659-18-057845-index.htm
2018-10-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918060747/0001104659-18-060747-index.htm
2018-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918063964/0001104659-18-063964-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066367/0001104659-18-066367-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918066998/0001104659-18-066998-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465918067217/0001104659-18-067217-index.htm
2018-11-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465918069011/0001104659-18-069011-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918072139/0001104659-18-072139-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918073844/0001104659-18-073844-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465918074466/0001104659-18-074466-index.htm
2019-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919002327/0001104659-19-002327-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919005844/0001104659-19-005844-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919007979/0001104659-19-007979-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010743/0001104659-19-010743-index.htm
2019-02-265Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010791/0001104659-19-010791-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010794/0001104659-19-010794-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010795/0001104659-19-010795-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010796/0001104659-19-010796-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010797/0001104659-19-010797-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010798/0001104659-19-010798-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010799/0001104659-19-010799-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010800/0001104659-19-010800-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010801/0001104659-19-010801-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919010802/0001104659-19-010802-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2019-03-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919012549/0001104659-19-012549-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919013142/0001104659-19-013142-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919016356/0001104659-19-016356-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919018296/0001104659-19-018296-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919019961/0001104659-19-019961-index.htm
2019-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023424/0001104659-19-023424-index.htm
2019-04-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1356576/000110465919023500/0001104659-19-023500-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919027555/0001104659-19-027555-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000110465919028593/0001104659-19-028593-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465919033130/0001104659-19-033130-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2019-07-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043062/0001104659-19-043062-index.htm
2019-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919043393/0001104659-19-043393-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465919076466/0001104659-19-076466-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920017388/0001104659-20-017388-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024847/0001104659-20-024847-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024848/0001104659-20-024848-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024849/0001104659-20-024849-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024850/0001104659-20-024850-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024913/0001104659-20-024913-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024915/0001104659-20-024915-index.htm
2020-02-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024919/0001104659-20-024919-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920024920/0001104659-20-024920-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000110465920026188/0001104659-20-026188-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920037450/0001104659-20-037450-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050721/0001104659-20-050721-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920050722/0001104659-20-050722-index.htm
2020-05-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1356576/000110465920056047/0001104659-20-056047-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920077403/0001104659-20-077403-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920100179/0001104659-20-100179-index.htm
2020-10-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114365/0001104659-20-114365-index.htm
2020-10-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920114367/0001104659-20-114367-index.htm
2020-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000010/0001356576-19-000010-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000015/0001356576-19-000015-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000019/0001356576-19-000019-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000025/0001356576-19-000025-index.htm
2019-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000030/0001356576-19-000030-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000033/0001356576-19-000033-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000041/0001356576-19-000041-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000043/0001356576-19-000043-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657619000045/0001356576-19-000045-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000047/0001356576-19-000047-index.htm
2019-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657619000049/0001356576-19-000049-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000002/0001356576-20-000002-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000004/0001356576-20-000004-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000006/0001356576-20-000006-index.htm
2020-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000010/0001356576-20-000010-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000015/0001356576-20-000015-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000018/0001356576-20-000018-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000020/0001356576-20-000020-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000023/0001356576-20-000023-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000025/0001356576-20-000025-index.htm
2020-05-12NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000029/0001356576-20-000029-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000031/0001356576-20-000031-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000033/0001356576-20-000033-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000035/0001356576-20-000035-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000037/0001356576-20-000037-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000041/0001356576-20-000041-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm
2020-08-11NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000048/0001356576-20-000048-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000050/0001356576-20-000050-index.htm
2020-08-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000054/0001356576-20-000054-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000056/0001356576-20-000056-index.htm
2020-08-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000059/0001356576-20-000059-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000062/0001356576-20-000062-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000064/0001356576-20-000064-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000066/0001356576-20-000066-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000068/0001356576-20-000068-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000070/0001356576-20-000070-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1356576/000135657620000072/0001356576-20-000072-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1356576/000135657620000076/0001356576-20-000076-index.htm
2018-11-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1356576/999999999718009168/9999999997-18-009168-index.htm

Supernus Pharmaceuticals, Inc (SUPN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Supernus Pharmaceuticals, Inc (SUPN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 361%
Institutional Ownership: 10146%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-06-29Padmanabh P. BhattSr. VP of IP, CSOSell4,393.0059.90263,153.000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-02-21Frederick M. HudsonDirectorBuy5,211.0023.99125,011.8910,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0049.88997,544.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell20,000.0052.031,040,558.0012,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOBuy7,205.009.1365,781.6514,705.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy7,500.009.1368,475.0015,000.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2020-07-13Frederick M. HudsonDirectorSell920.0024.4422,484.8018,041.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy10,882.009.24100,549.6818,382.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2020-07-13Frederick M. HudsonDirectorBuy8,750.002.5622,400.0018,961.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOSell60,000.0054.393,263,352.001,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy20,000.007.90158,000.0021,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy11,250.009.24103,950.0023,750.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy8,722.007.9068,903.8028,285.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-05-10Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOBuy20,000.007.90158,000.0032,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-08-20JOHN M SIEBERTDirectorBuy7,457.009.2468,902.6835,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOSell3,402.0059.94203,899.214,393.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOSell15,000.0020.03300,507.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOSell5,000.0023.00115,000.0044,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2019-04-25JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0045,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerSell15,000.0023.14347,034.0046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerSell15,000.0025.03375,379.5046,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2019-08-23Jack A. KhattarPresident, CEOBuy7,200.0026.39189,982.08465,141.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerSell20,000.0041.53830,650.0047,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2020-07-10Jack A. KhattarPresident, CEOBuy15,625.00490,841.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm
2020-11-05GREGORY S PATRICKSr. VP, CFOBuy5,000.0012.9864,900.0049,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm
2020-07-27Jack A. KhattarPresident, CEOBuy15,625.00506,466.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm
2020-02-21Carrolee BarlowDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm
2020-02-21GEORGES GEMAYELDirectorBuy5,211.0023.99125,011.895,211.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm
2019-06-20JOHN M SIEBERTDirectorBuy10,000.009.1391,300.0055,742.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerSell35,000.0056.631,981,913.5055,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-10-15GREGORY S PATRICKSr. VP, CFOBuy15,000.0012.98194,700.0059,463.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm
2020-02-21JOHN M SIEBERTDirectorBuy5,211.0023.99125,011.8960,953.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm
2020-05-08GREGORY S PATRICKSr VP, Chief Financial OfficerBuy15,000.009.13136,950.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm
2020-05-20GREGORY S PATRICKSr.VP, Chief Financial OfficerBuy15,000.0012.98194,700.0061,057.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm
2018-06-18Stefan K.F. SchwabeExecutive VP R&D, CMOBuy40,000.009.24369,600.0061,967.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm
2019-02-27GREGORY S PATRICKSr VP, Chief Financial OfficerBuy20,000.009.13182,600.0067,896.00https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell16,250.0055.23897,542.757,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-11Padmanabh P. BhattSr. VP of IP, CSOSell10,882.0057.90630,067.807,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOSell368.0057.9321,316.627,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-06-21Padmanabh P. BhattSr. VP of IP, CSOSell7,205.0060.00432,323.067,500.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy20,000.009.24184,800.0075,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2018-06-28Padmanabh P. BhattSr. VP of IP, CSOBuy295.009.132,693.357,795.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm
2018-05-15Padmanabh P. BhattSr. VP of IP, CSOBuy368.009.243,400.327,868.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm
2018-07-02GREGORY S PATRICKVP, Chief Financial OfficerBuy15,000.009.13136,950.0090,975.00https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm
2020-02-21CHARLES W III NEWHALLDirectorBuy5,211.0023.99125,011.8997,509.00https://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm